Honz Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Honz Pharmaceutical has a total shareholder equity of CN¥1.3B and total debt of CN¥537.7M, which brings its debt-to-equity ratio to 41.9%. Its total assets and total liabilities are CN¥2.1B and CN¥805.3M respectively.
Key information
41.9%
Debt to equity ratio
CN¥537.74m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥123.63m |
| Equity | CN¥1.28b |
| Total liabilities | CN¥805.33m |
| Total assets | CN¥2.09b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 300086's short term assets (CN¥522.3M) exceed its short term liabilities (CN¥475.7M).
Long Term Liabilities: 300086's short term assets (CN¥522.3M) exceed its long term liabilities (CN¥329.6M).
Debt to Equity History and Analysis
Debt Level: 300086's net debt to equity ratio (32.3%) is considered satisfactory.
Reducing Debt: 300086's debt to equity ratio has increased from 14.4% to 41.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 300086 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: 300086 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 10.7% each year